HemaSphere (Jun 2022)

P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

  • J. Martínez-López,
  • P. Moreau,
  • S. Z. Usmani,
  • A. Garfall,
  • N. W. van de Donk,
  • J. F. San-Miguel,
  • A. Oriol,
  • A. Chari,
  • L. Karlin,
  • M.-V. Mateos,
  • R. Popat,
  • A. K. Nooka,
  • S. Sidana,
  • D. Trancucci,
  • R. Verona,
  • S. Girgis,
  • C. Uhlar,
  • T. Stephenson,
  • A. Banerjee,
  • A. Krishnan

DOI
https://doi.org/10.1097/01.HS9.0000846552.63695.9d
Journal volume & issue
Vol. 6
pp. 811 – 812

Abstract

Read online

No abstracts available.